Posts

Showing posts from May, 2024

Doctor is struck off for trying to sell unproven treatments to patient with advanced cancer | The BMJ

Image
Julian Kenyon was interviewed by the BBC Inside Out programme in 2003 Doctor is struck off for trying to sell unproven treatments to patient with advanced cancer | The BMJ bmj.com Clare Dyer   A doctor who put pressure on a patient with advanced cancer to pay £13,000 for alternative treatments, including sound and light therapy, has been struck off. Julian Kenyon, 77, ran the former Dove Clinic, a private health centre at Twyford, Hampshire . News BMJ 2024 ; 385 doi: https://doi.org/10.1136/bmj.q1192 (Publi...

More Evidence Backs Active Surveillance for Low-Risk Prostate Cancer | MedPage Today

Image
    The Long-Term Risks of Metastases in Men on Active Surveillance for Early Stage Prostate Cancer Summary The study analyzed the long-term outcomes of 2,155 men with favorable-risk prostate cancer managed with active surveillance in the Canary Prostate Active Surveillance Study (PASS). Key findings after 10 years of follow-up include: 43% of patients had biopsy grade reclassification, and 49% received treatment. Patients treated after confirmatory biopsies (median 1.5 years) had a 5-year recurrence rate of 11%, while those treated after subsequent surveillance biopsies (median 4.6 years) had a recurrence rate of 8%. 21 patients (1%) developed metastatic cancer, and 3 died of prostate cancer. The estimated unfavorable outcomes were: overall mortality was (5.1%) 10-year rates of metastasis (1.4%),  prostate cancer-specific mortality (0.1%) The results suggest that protocol-directed active surveillance with regular PSA exams and prostate biopsies is a safe and effective ma...

Clinical and histopathological parameters in transrectal ultrasound‐guided biopsies associated with tumor upgrading after radical prostatectomy: A comparative analysis of risk groups - Ozkaya - The Prostate - Wiley Online Library

Image
Clinical and histopathological parameters in transrectal ultrasound‐guided biopsies associated with tumor upgrading after radical prostatectomy: A comparative analysis of risk groups - Ozkaya - The Prostate - Wiley Online Library onlinelibrary.wiley.com Mustafa Ozkaya MD Summary In simple terms, this study looked at factors that might predict if a man's prostate cancer is worse than originally thought based on the initial biopsy. They studied 205 men diagnosed with prostate cancer who later had their prostate removed. Key takeaways: - Men were classified as low, intermediate, or high risk. High risk men tended to be older with higher PSA levels (a blood test for prostate cancer). - About half had abnormal cells called HGPIN in non-cancerous parts of their biopsy. This was more common in low and intermediate risk men. - After surgery, the cancer grade was often worse than the biopsy suggested, especiall...